Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Hypercholesterolemia also known as high cholesterol, is the presence of excess levels of cholesterol in the body that increases a risk of developing heart attack, and stroke. Changes in lifestyle pattern such as the adoption of a sedentary form, increasing rate alcohol consumption and change in dietary pattern are driving the growth of hypercholesterolemia drugs market. For the purpose of the study hypercholesterolemia drugs market is segmented on the basis of drug class such as HMG-CoA reductase inhibitors/ statins, bile acid sequestrants, fibrates, cholesterol absorption inhibitors, others drugs. It is studied that, currently HMG-CoA reductase inhibitors/ statins held largest market share because statins are commonly prescribed drug class due to their safety and effectiveness in lowering cholesterol.The Americas dominated the global hypercholesterolemia drugs market and accounted for most of the market share in terms of revenue. This market is expected to witness declining growth, owing to competition from the generic versions of branded drugs.
The report details the trend, potential and market size of Hypercholesterolemia Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Hypercholesterolemia Drugsmarket, defines the market attractiveness level of Hypercholesterolemia Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Hypercholesterolemia Drugs industry, describes the types of Hypercholesterolemia Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hypercholesterolemia Drugs market and the development prospects and opportunities of Hypercholesterolemia Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hypercholesterolemia Drugs market in Chapter 13.
By Player:
Aegerion Pharmaceuticals
AstraZeneca
Merck
Pfizer
Sanofi
AbbVie
By Type:
Statins
Non-Statins
By End-User:
FH
Non-FH
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Hypercholesterolemia Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Hypercholesterolemia Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Hypercholesterolemia Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Hypercholesterolemia Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Hypercholesterolemia Drugs Market Analysis and Outlook to 2022
-
7.1 Global Hypercholesterolemia Drugs Consumption (2017-2022)
-
7.2 United States Hypercholesterolemia Drugs Consumption (2017-2022)
-
7.3 Europe Hypercholesterolemia Drugs Consumption (2017-2022)
-
7.4 China Hypercholesterolemia Drugs Consumption (2017-2022)
-
7.5 Japan Hypercholesterolemia Drugs Consumption (2017-2022)
-
7.6 India Hypercholesterolemia Drugs Consumption (2017-2022)
-
7.7 South Korea Hypercholesterolemia Drugs Consumption (2017-2022)
8 Region and Country-wise Hypercholesterolemia Drugs Market Analysis and Outlook to 2028
-
8.1 Global Hypercholesterolemia Drugs Consumption Forecast (2022-2028)
-
8.2 United States Hypercholesterolemia Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Hypercholesterolemia Drugs Consumption Forecast (2022-2028)
-
8.4 China Hypercholesterolemia Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Hypercholesterolemia Drugs Consumption Forecast (2022-2028)
-
8.6 India Hypercholesterolemia Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Hypercholesterolemia Drugs Consumption Forecast (2022-2028)
9 Global Hypercholesterolemia Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Hypercholesterolemia Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Statins Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Non-Statins Consumption and Growth Rate (2017-2022)
-
9.2 Global Hypercholesterolemia Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global FH Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Non-FH Consumption and Growth Rate (2017-2022)
10 Global Hypercholesterolemia Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Hypercholesterolemia Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Statins Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Non-Statins Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Hypercholesterolemia Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global FH Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Non-FH Consumption Forecast and Growth Rate (2022-2028)
11 Global Hypercholesterolemia Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Hypercholesterolemia Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Hypercholesterolemia Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Hypercholesterolemia Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Hypercholesterolemia Drugs Market Competitive Analysis
-
14.1 Aegerion Pharmaceuticals
-
14.1.1 Aegerion Pharmaceuticals Company Details
-
14.1.2 Aegerion Pharmaceuticals Hypercholesterolemia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Aegerion Pharmaceuticals Hypercholesterolemia Drugs Product and Service
-
14.2 AstraZeneca
-
14.2.1 AstraZeneca Company Details
-
14.2.2 AstraZeneca Hypercholesterolemia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 AstraZeneca Hypercholesterolemia Drugs Product and Service
-
14.3 Merck
-
14.3.1 Merck Company Details
-
14.3.2 Merck Hypercholesterolemia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Merck Hypercholesterolemia Drugs Product and Service
-
14.4 Pfizer
-
14.4.1 Pfizer Company Details
-
14.4.2 Pfizer Hypercholesterolemia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer Hypercholesterolemia Drugs Product and Service
-
14.5 Sanofi
-
14.5.1 Sanofi Company Details
-
14.5.2 Sanofi Hypercholesterolemia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Sanofi Hypercholesterolemia Drugs Product and Service
-
14.6 AbbVie
-
14.6.1 AbbVie Company Details
-
14.6.2 AbbVie Hypercholesterolemia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 AbbVie Hypercholesterolemia Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Hypercholesterolemia Drugs
-
Figure Hypercholesterolemia Drugs Picture
-
Table Global Hypercholesterolemia Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hypercholesterolemia Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hypercholesterolemia Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Hypercholesterolemia Drugs Consumption by Country (2017-2022)
-
Figure United States Hypercholesterolemia Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Hypercholesterolemia Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Hypercholesterolemia Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Hypercholesterolemia Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Hypercholesterolemia Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Hypercholesterolemia Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Hypercholesterolemia Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Hypercholesterolemia Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Hypercholesterolemia Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Hypercholesterolemia Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Hypercholesterolemia Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Hypercholesterolemia Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Hypercholesterolemia Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Statins Consumption and Growth Rate (2017-2022)
-
Figure Global Non-Statins Consumption and Growth Rate (2017-2022)
-
Figure Global FH Consumption and Growth Rate (2017-2022)
-
Figure Global Non-FH Consumption and Growth Rate (2017-2022)
-
Figure Global Statins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-Statins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global FH Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-FH Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Hypercholesterolemia Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Hypercholesterolemia Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Aegerion Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Aegerion Pharmaceuticals Hypercholesterolemia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aegerion Pharmaceuticals Hypercholesterolemia Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Hypercholesterolemia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Hypercholesterolemia Drugs Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Hypercholesterolemia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Hypercholesterolemia Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Hypercholesterolemia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Hypercholesterolemia Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Hypercholesterolemia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Hypercholesterolemia Drugs Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Hypercholesterolemia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Hypercholesterolemia Drugs Product and Service
-
